Search

Anderson, Kelsey L, Rajsavi Anand, and Joseph D Feuerstein. 2024. “Insurance Companies’ Poor Adherence to Guidelines for Moderate-to-Severe Ulcerative Colitis/Crohn’s Disease Management.”. The American Journal of Gastroenterology.

Zitomersky, Naamah, Lisa Chi, Enju Liu, Kurtis R Bray, Konstantinos Papamichael, Adam S Cheifetz, Scott B Snapper, Athos Bousvaros, and Jocelyn A Silvester. 2024. “Anti-Infliximab Antibodies and Low Infliximab Levels Correlate With Drug Discontinuation in Pediatric Inflammatory Bowel Disease.”. Journal of Pediatric Gastroenterology and Nutrition 78 (2): 261-71.

Dong, Jeffrey, Hyder Said, Samuel J Miller, Hannah K Systrom, and Joseph D Feuerstein. 2024. “Disparities in Rates of Multitarget Stool DNA Test Completion for Colorectal Cancer Screening.”. Journal of Clinical Gastroenterology 58 (8): 805-9.

Feld, Lauren D, Amy S Oxentenko, Dawn Sears, Aline Charabaty, Loren G Rabinowitz, and Julie K Silver. 2023. “Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2709-15.

Roblin, Xavier, Gérard Duru, Konstantinos Papamichael, Adam S Cheifetz, Sandy Kwiatek, Anne-Emmanuelle Berger, Mathilde Barrau, Louis Waeckel, Stéphane Nancey, and Stephane Paul. 2023. “Development of Antibodies to Ustekinumab Is Associated With Loss of Response in Patients With Inflammatory Bowel Disease.”. Journal of Clinical Medicine 12 (10).

Shah, Ishani, Andy Silva-Santisteban, Katharine A Germansky, Arvind Trindade, Kara L Raphael, Vladimir Kushnir, Rishi Pawa, et al. 2023. “Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study.”. The American Journal of Gastroenterology 118 (9): 1664-70.

Hasan, Syed S, Sarah Ballou, Laurie Keefer, and Dipesh H Vasant. 2023. “Improving Access to Gut-Directed Hypnotherapy for Irritable Bowel Syndrome in the Digital Therapeutics’ Era: Are Mobile Applications a ‘smart’ Solution?”. Neurogastroenterology and Motility 35 (4): e14554.

Johnson, Amanda M, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan Galati, Vipul Jairath, Neeraj Narula, et al. 2023. “The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn’s Disease: Results From the SUCCESS Consortium.”. The American Journal of Gastroenterology 118 (2): 317-28.

Ongaro, Giulio, Sarah Ballou, Tobias Kube, Julia Haas, and Ted J Kaptchuk. 2023. “Doctors Speak: A Qualitative Study of Physicians’ Prescribing of Antidepressants in Functional Bowel Disorders.”. Culture, Medicine and Psychiatry 47 (3): 669-83.

Papamichael, Konstantinos, Waqqas Afif, David Drobne, Marla C Dubinsky, Marc Ferrante, Peter M Irving, Nikolaos Kamperidis, et al. 2022. “Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: Unmet Needs and Future Perspectives.”. The Lancet. Gastroenterology & Hepatology 7 (2): 171-85.